Blis Technologies Ltd operates within the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Blis Technologies Ltd with three other
pharmaceutical manufacturers in Australasia:
sales of 5.29 million Australian Dollars [US$3.64 million]
of which 12%
Avita Medical Limited
(8.16 million Australian Dollars [US$5.62 million]
of which 76%
was Operating-Americas.), and
based in Australia
(5.31 million Australian Dollars [US$3.66 million]
of which 100%
was Manufacturing of ultra lightweight carbo).
During the year ended March of 2019, sales at
Blis Technologies Ltd were 8.41 million New Zealand Dollars (US$5.35 million).
increase of 59.0%
versus 2018, when the company's sales were 5.29 million New Zealand Dollars.